Delivery Order SPE2DB22D3102-SPE2DB25FL0BR
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lamotrigine ER 50 mg tablets. The contract has a ceiling value of $2,178.05 and an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,896.92 and runs through April 30, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,248.34, is for the supply of Lamotrigine ER 50 mg tablets. It is a firm fixed-price contract with a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ER 50 mg tablets, a medication used to treat mental health conditions. The total ceiling value of the contract is $7,532.02, and it is a Firm Fixed Price Delivery Order type contract that runs through February 12, 2025. The contract does not have a set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 50 mg tablets. The contract has a firm fixed price of $6,063.48 and a period of performance through February 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566320992 units of Lamotrigine ODT 100 mg Tablets. The contract has a ceiling value of $1,564.64 and will run through November 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,085.64, is a firm-fixed-price delivery order with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of LAMOTRIGINE ER 250 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,610.84. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of July 23, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 200 mg Tablets in quantities of 30. The $3,349.80 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $2,990.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for Lamotrigine ER 50 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...